| 000 | 01417 a2200421 4500 | ||
|---|---|---|---|
| 005 | 20250517114659.0 | ||
| 264 | 0 | _c20171117 | |
| 008 | 201711s 0 0 eng d | ||
| 022 | _a1536-3694 | ||
| 024 | 7 |
_a10.1097/FTD.0000000000000321 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aPointreau, Yoann | |
| 245 | 0 | 0 |
_aCetuximab Pharmacokinetics Influences Overall Survival in Patients With Head and Neck Cancer. _h[electronic resource] |
| 260 |
_bTherapeutic drug monitoring _c10 2016 |
||
| 300 |
_a567-72 p. _bdigital |
||
| 500 | _aPublication Type: Clinical Trial; Journal Article | ||
| 650 | 0 | 4 | _aAdult |
| 650 | 0 | 4 | _aAged |
| 650 | 0 | 4 | _aAged, 80 and over |
| 650 | 0 | 4 |
_aAntibodies, Monoclonal, Humanized _xblood |
| 650 | 0 | 4 |
_aCarcinoma, Squamous Cell _xblood |
| 650 | 0 | 4 |
_aCetuximab _xblood |
| 650 | 0 | 4 | _aDisease-Free Survival |
| 650 | 0 | 4 | _aFemale |
| 650 | 0 | 4 |
_aHead and Neck Neoplasms _xblood |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 | _aMiddle Aged |
| 650 | 0 | 4 | _aModels, Biological |
| 650 | 0 | 4 | _aRetrospective Studies |
| 650 | 0 | 4 | _aSquamous Cell Carcinoma of Head and Neck |
| 700 | 1 | _aAzzopardi, Nicolas | |
| 700 | 1 | _aTernant, David | |
| 700 | 1 | _aCalais, Gilles | |
| 700 | 1 | _aPaintaud, Gilles | |
| 773 | 0 |
_tTherapeutic drug monitoring _gvol. 38 _gno. 5 _gp. 567-72 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1097/FTD.0000000000000321 _zAvailable from publisher's website |
| 999 |
_c26421594 _d26421594 |
||